The present study reports the influence of muscimol and/ or reduced chloride concentrations on amino acid release from synaptosomes prepared from the cerebral cortex of female Sprague-Dawley rats (180-250 g) (Dodd et al., 198 1) . Intrasynaptosomal chloride concentration was manipulated by incubating synaptosomes (1 mg synaptosomal protein/ml, final concentration), after 15 min preincubation, for 30 min at 37" C in Krebs medium containing either (i) muscimol ( 1 0~~) or (ii) a reduced chloride concentration (48 or 1 15 mM-Cl-), sodium isethionate replaced sodium chloride. When bicucculine (10 PM) or baclofen ( 1 0~~) were tested they were added after dilution of the pre-incubated synaptosomes. Bicucculine, if present, was allowed to act for 5 min at 37°C before muscimol was added. Incubations were teminated by centrifugation of the synaptosomes at lOOOOg for 3min. Amino acid analysis was performed on the synaptosome pellet (after addition of methanol containing an appropriate quantity of norleucine in 0.025 N-HCl as internal standard, and freezing to -20°C and thawing), and on the incubation medium as previously described (Docherty et al., 1985) . When solutions of muscimol alone were prepared for amino acid analysis, one major fluorescent (orthophthaldialdehyde) product could be detected in the resultant chromatogram. This peak ran very close to, but was distinct from, the peak produced by GABA. Potassium content was estimated as before (Docherty et al., 1985) .
It can be seen that exposure to muscimol caused a large increase in the release of aspartate and glutamate while the release of GABA and histidine was stimulated to a lesser extent ( Table 1) . This stimulated release could be blocked by pre-incubation of the synaptosomes with bicucculine (Table 1) demonstrating that the stimulated release occurred as a result of GABA, receptor activation. Neither glycine nor any metabolic amino acids (e.g. threonine, serine) showed stimulated release. Synaptosomal potassium levels were reduced to 68 f 6% (mean f s.D., n = 6) of control levels. Reduced chloride concentrations produced qualitatively similar effects in agreement with previous studies (Hardy et al., 1984; Naalsund & Fonnum, 1986) . Potassium levels fell to 80 f 9% (mean f s.D., n = 6) of control levels when 48 mM-Cl-was tested. Baclofen had no significant effect on amino acid release or potassium content (results not shown).
The data presented are consistent with a depolarizing rather than a hyperpolarizing action of muscimol as a direct result of chloride efflux induced by GABA, receptor stimulation. This phenomenon could explain the mechanism whereby muscimol enhances the immunolysis of cholinergic synaptosomes (Docherty & Bradford, 1987a, h) . It is possible, however, that the stimulated release observed is secondary to the relief of one or more inhibitory mechanisms. Reduction in amino acid release was not observed following muscimol treatment. If relief of inhibitory influence(s) is responsible for the effects seen, it is unlikely that this involves amino acids.
Dendrotoxin (DTX) and homologous toxins (e.g. toxin I) from mamba venoms are convulsant polypeptides that facilitate neurotransmitter release at peripheral (Harvey & Karlsson, 1982; Harvey et al., 1984) and central (Dolly et al., 1984) synapses. Their action at chick neuromuscular junction is antagonized (Harvey & Karlsson, 1982) by P-bungarotoxin (P-BuTX), a presynaptic neurotoxin which blocks transmitter release at the neuromuscular junction (Abe et al., 1977) and mammalian central synapses (Halliwell & Dolly, 1982) . Recently, DTX and toxin I have been shown to block selectively certain rapidly activating voltagesensitive K f conductances such as the A-current in hippocampal pyramidal cells (Dolly et a[., 1984; Halliwell et al., 1986) , a similar slowly inactivating K+-current in rat nodose ganglion A-cells , and a component of the fast K + -current in the frog node of Ranvier Abbreviations used: DTX, dendrotoxin; p-BuTX, P-bungarotoxin. (Benoit & Dubois, 1986) . In fact, the slowly inactivating sub-types of these K+ -conductances are more sensitive to these toxins (Dolly et al., 1987) . Using biologically active radiolabelled derivatives of DTX and P-BuTX, high-affinity (Kd = 0.2-0.4nM) acceptors for both toxins have been identified in synaptic membranes with a stoichiometry of DTX: fl-BuTX acceptors of -3 : 1 (Dolly et al., 1984; Dolly et al., 1987) . The binding of '2sI-labelled P-BuTX to synaptosomes is inhibited completely and with high affinity by DTX (Dolly et al., 1987) , while, in accordance with the greater number of DTX acceptors, fl-BuTX fails to compete for a large proportion of '251-labelled DTX binding with similar potency (Black et al., 1986; Dolly et al., 1987 ). It appears, therefore, that there are at least two sub-classes of DTX acceptors, only one of which exhibits a high affinity for P-BuTX .
In the present study, the distribution of acceptors for '*'I-labelled DTX and P-BuTX in rat brain was examined by quantitative in vitro autoradiography using 'H-sensitive Ultrofilm (Unnerstall et al., 1982) . High-affinity (Kd = 1.7 nM) acceptors for '251-labelled P-BuTX were detected on cryostat sections of rat forebrain; these were localized in synapse-rich grey matter. Using a saturating concentration of ' 2 5 I-labelled P-BuTX (2.5 nM), the molecular layer of the Vol. 15 BIOCHEMICAL SOCIETY TRANSACTIONS Table I . Quantitative distribution of acceptors for DTX and P-BuTX in rat brain Brain cryostat sections (10pm; average protein content 1 .2pg/mm2) were incubated in 2.5 nM-12sI-labelled 8-BuTX or I-labelled DTX and exposed to H-sensitive Ultrofilm, together with 12SI-labelled brain paste standards (Unnerstall et al., 1982) . Autoradiograms were analysed by laser densitometry. Non-specific binding, determined in the presence of 1 pM-unlabelled toxin, has been subtracted. Values represent mean f S.E.M. of three experiments. dentate gyms was most prominently labelled followed by frontal cerebral cortex and caudate putamen (Table 1) . Labelling in synaptic layers was more prominent than in the cell body regions of the hippocampus or cerebellum. Only low levels of '2sI-labelled P-BuTX binding (0.06-0.1 1 fmol/ mm2) were found in white matter tracts (e.g. corpus callosum, anterior commissure). i2SI-labelled DTX likewise showed high affinity (& = 1 . 2~) binding to rat brain sections, the content of sites (Bmax) being approximately 3-4 fold higher than that for I-labelled /7-BuTX. As for 125 I-labelled P-BuTX, extensive labelling with '*'I-labelled DTX (2.5 nM) was observed in grey matter areas (Table 1) ; again synaptic layers in the hippocampal formation and cerebellum were labelled more strongly than the nearby cell body layers. However, in addition, white matter tracts contained high levels of DTX acceptors (0.54-0.65 fmol/mm2). Furthermore, in agreement with these results, a large proportion of the binding of 12sI-labelled DTX was blocked on sections incubated in 2 . 5 n~-'~~I -l a b e l l e d DTX together with an excess (1 PM) of unlabelled /7-BuTX, the residual P-BuTX-resistant binding occurring predominantly in white matter tracts and areas containing a large proportion of myelinated fibres.
The widespread distribution of DTX acceptors, particularly along nerve fibre tracts, agrees well with the distribution of K + -channels. In synaptic areas these channels regulate neurotransmitter release, while on cell bodies they control excitation and firing frequency of neurons . Thus, it is tempting to relate the sub-types of DTX acceptors observed to the DTX-sensitive K + -channel variants distinguished electrophysiologically.
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